• Conference program

    Wednesday 20th October 2010
     

    17:00 Registration
    18:00 Opening Address
    Professor Richard Carter, The University of Edinburgh, UK
    18:45 Poster viewing
    20:00 End of Day 1

    Thursday 21st October 2010

    08:00 Registration & Coffee
    08:30 Keynote Address
    Epidemiology of malaria resistance or Artemisinin: resistance or temporary tolerance
    Carol Sibley, University of Washington, USA

    Session 1: Advances in understanding parasite biology and host-parasite interactions that are relevant to disease and treatment
    Chair: Kiaran Kirk, The Australian National University, Australia

     

    09:00 Invasion and modification of the host erythrocyte
    Brendan Crabb, Burnet Institute, Australia
    09:20 Stepwise dissection of Plasmodium falciparum merozoite invasion of the human erythrocyte
    Jake Baum, Walter and Eliza Hall Institute, Australia
    09:35 Liver stage malaria
    Maria M. Mota, Institute of Molecular Medicine, Portugal
    09:55 Transporters of parasites as drug targets: tempting but underexploited
    Henry Staines, St George's University of London, UK
    10:15 Polyamine uptake in the malaria parasite, Plasmodium falciparum, is dependent on the parasite’s membrane potential
    Braam Louw, University of Pretoria, South Africa
    10:30 A comprehensive survey of protein palmitoylation in late blood-stage Plasmodium falciparum
    Matthew L.Jones, Wellcome Trust Sanger Institute, UK
    10:45 Coffee Break

    Session 2: Assimilating genome-wide analyses of parasites to provide new tools for vaccines and drug discovery projects, as well as understanding the mechanisms of resistance
    Chair: Stephen Ward, Liverpool School of Tropical Medicine, UK

     

    11:15 Metabolomics approaches to understanding host parasite interaction
    Kellen Olszewski, Princeton University, USA
    11:35 Systematic gene knockout in P. berghei for analysis gene functions. Current status, how to extrapolate to human parasites.
    Olliver Billker, The Wellcome Trust Sanger Institute, UK
    11:55 Understanding Plasmodium sexual stage and zygote development and their translation
    Andy Waters, University of Glasgow UK
    12:15 Investigating transcriptional regulation of Plasmodium falciparum upon drug perturbation
    Tharina van Brummelenssion, CSIR, South Africa
    12:30 Ancient out-of-Africa migration of Plasmodium falciparum along with modern humans
    Kazuyuki Tanabe, Osaka University, Japan
    12:45 A library of functional recombinant Plasmodium falciparum merozoite surface proteins
    Cecile Wright-Crosnier, Wellcome Trust Sanger Institute
    13:00 Lunch

    Session 3: Vector biology: New approaches to vector control of plasmodium parasites
    Chair: Hilary Hurd, Keele University, School of Life Sciences

     

    14:00 Push-pull strategies for vector control
    Willem Takken, Wageningen University, Netherlands
    14:20 Studies on the breeding swarms of Anopheles gambiae complex in malaria control perspective
    Benoît S. Assogba, Benin
    14:35 Larval time-to-hatch and insecticide resistance in the major malaria vector Anopheles gambiae from Ghana
    Basil Brooke, National Institute for Communicable Diseases, Johannesburg
    14:50 Characterization and comparative sequence analyzes of GABA receptor gene in Asian main malaria mosquito, Anopheles stephensi
    Navid Dinparast Djadid, Pasteur Institute of Iran, Iran
    15:05 Sugar-fermenting yeast as an organic source of carbon dioxide to attract the malaria mosquito Anopheles gambiae s.s.
    Renate Smallegange, Wageningen University, The Netherlands
    15:20 Intra-host dynamics of mixed species malaria parasite infections in mice and mosquitoes
    Richard Culleton, Nagasaki University, Japan
    15:35 The role of LCCL proteins in malaria transmission
    Sadia Saeed, London School of Hygiene & Tropical Medicine, UK
    15:50 Coffee Break

    Session 4: Emerging parasites: Recently discovered knowlesi in humans that is providing new insights into pathophysiology of malarial infections
    Chair: David Sullivan, Johns Hopkins University, USA

     

    16:05 Insights from monkey malaria that can change thinking about human infections
    Janet Cox-Singh, St George's University of London, UK
    16:25 P. ovale
    Colin Sutherland, London School of Hygiene & Tropical Medicine, UK
    16:55 P vivax: The Duffy dogma revisited
    Peter Zimmerman, Case Western Reserve University, USA
    17:15 Adaptation of in vitro cytoadherence assay to Plasmodium knowlesi field isolates
    Farrah A Fatih, St George’s University of London, UK
    17:30 Origin of the human malaria parasite Plasmodium falciparum in gorillas
    Julian C Rayner, Wellcome Trust Sanger Institute, UK
    17:45 Wild chimpanzees are infected with homologous types of human malaria
    Marco Kaiser, Robert Koch-Institute, Germany
    18:00 Poster Viewing
    19:00 End of Day 2
    19:30 Coaches depart for dinner
    20:00 Conference Dinner at Dynamic Earth

    Friday 22nd October 2010

    Session 5: Revisiting the sequestration and cytokine/mediator models for pathogenesis
    Chair: Sanjeev Krishna, St George’s University of London, UK

     

    08:30 Coffee
    09:00 Var2CSA binding
    Ali Salanti, University of Copenhagen, Denmark
    09:20 Retinopathy and microcirculation in adult severe malaria
    Richard J Maude, Mahidol -Oxford Tropical Medicine Research Unit, Thailand
    09:40 Variant surface antigens in cerebral malaria: distinct from others and similar to each other?
    Agnès Aubouy, Institut de Recherche pour le Développement (IRD), France
    09:55 Transfer of 4-hydroxynonenal, a inhibitory hemozoin (HZ) product, from HZ or HZ-laden phagocytes to developing human erythroid cells. A model for erythropoiesis inhibition in malaria anemia
    Paolo Arese, University of Torino Medical School, Italy
    10:10 Molecular Epidemiology of Force of Infection in malaria
    Ingrid Felger, Swiss Tropical and Public Health Institute, Switzerland
    10:25 Immunopathology and Dexamethasone Therapy in a new Model for Malaria-Associated Acute Respiratory Distress Syndrome
    Philippe E. Van den Steen, University of Leuven, Belgium
    10:40 Coffee

    Session 6: Drug discovery - renewed vision and role in malaria control and elimination
    Chair: Henri Vial, CNRS University of Montpellier

     

    11:10 Keynote Address
    New drug treatments in the portfolio
    Tim Wells, Medicines for Malaria Venture (MMV), Switzerland
    11:40 Basic biology
    Stephen Ward, Liverpool School of Tropical Medicine, UK
    12:00 Refreshed approaches to the therapy of malaria – the case of natural medicine
    Hagai Ginsburg, The Hebrew University of Jerusalem, Israel
    12:20 Progress in the development of Reversed Chloroquine molecules as antimalarial therapy
    David H. Peyton, Portland State University, USA
    12:35 Identification and characterization of novel Plasmodium falciparum cyclophilins and their roles in the antimalarial actions of cyclosporin A and derivatives
    Angus Bell, Trinity College Dublin, Ireland
    12:50 Development of a Novel Drug for Uncomplicated Malaria Targeting the Mitochondrial NADH: Quinone Oxidoreductase
    Giancarlo Biagini, Liverpool School of Tropical Medicine, UK
    13:05 Antimalarial activity of ulein and a proof of its action on the Plasmodium falciparum digestive vacuole
    Alaíde Braga, Universidade Federal de Minas Gerais, Brazil
    13:25 Identification of genetic markers of resistance to Artemisinin Combination Therapy in the rodent model Plasmodium chabaudi
    Louise Rodrigues, Instituto Instituto de Higiene e Medicina Tropical Universidade Nova de Lisboa, Portugal
    13:40 Lunch

    Session 7: Immunology and vaccine development
    Chair: Alister Craig, Liverpool School of Tropical Medicine UK

     

    14:25 Sanaria malaria extraction through vaccination
    Dr. Peter Billingsley, Sanaria, USA
    14:45 Viral vectored transmission blocking vaccines against Plasmodium falciparum
    Melissa Kapulu, University of Oxford, UK
    15:00 Impact of protective haemoglobins C and S on P. falciparum malaria transmission in endemic area
    Louis-Clément Gouagna, Institut de Recherche pour le Développement, France
    15:15 Complete abrogation of sporozoite-induced sterile immunity by blood stage parasites of homologous and heterologous malaria species
    Megumi Inoue, Nagasaki University, Japan
    15:30 Predicted impact of mosquito-stage transmission-blocking vaccines using an ensemble of microsimulations
    Aurelio Di Pasquale, Swiss Tropical and Public Health Institute, Switzerland
    15:45 A micro-bead device to explore Plasmodium falciparum-infected, spherocytic or aged red blood cells prone to mechanical retention by spleen endothelial slits
    Innocent Safeukui, Institut Pasteur, France
    16:00 Coffee

    Session 8: Disease Control: Vector control options are constantly evolving, whether by pesticide, sterile insect technique or biological control. What else is on the horizon?
    Chair: Marcel Hommel, University of Liverpool, Editor-in-Chief, Malaria Journal, UK

     

    16:25 The elimination roadmap
    Marcel Tanner, Swiss Tropical and Public Health Institute, Switzerland
    16:45 Integrated vector management (IVM): from concept to practice
    Henk van den Berg, Laboratory of Entomology, Wageningen University, The Netherlands
    17:05 Modeling the effects of vector control interventions in reducing malaria transmission, morbidity and mortality
    Konstantina Boutsika, Swiss Tropical & Public Health Institute, Switzerland
    17:20 Controlling malaria in Niger with bednets: how to take the Big Picture?
    Jean-Bernard Duchemin, Institut Pasteur, France
    17:35 Household size explains successful malaria eradication
    Lena Hulden, University of Helsinki, Finland
    17:40 What has been the contribution of the first Global Fund grant (2003-2006) to malaria control and health system strengthening in Timor-Leste?
    Joao S Martins, University of New South Wales, Australia
    17:55 Closing remarks
    18:05 Close of Day 3
  • Challenges in Malaria Research

  • Contact us

    General enquiries

    Email:  events@biomedcentral.com

    UK call:  0800 389 8136

    Outside UK call:  +44 (0) 20 3192 2009

  • Conference supporters

     

     

  • Conference sponsors

     

     

     

  • Conference media partners

  • Journal

    Malaria Journal is a peer-reviewed, open access journal publishing exclusively articles on malaria. It aims to bring together knowledge from the different specialties involved in this very broad discipline, from the bench to the bedside.

powered by amiando

Event organizer: BioMed Central
conference - Online Event Management with the ticketing solution from XING Events

Imprint